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Among the current armamentarium of cardiac imaging
techniques, cardiac magnetic resonance imaging (CMR) is
superior in its ability to characterize the composition of
myocardial tissue. CMR has the capacity to noninvasively
quantify abnormal areas of edema (1), intra- and extracel-
lular fat (2), and ﬁbrosis (3). This ability may permit the
identiﬁcation of injury at earlier stages of disease or in hearts
that might otherwise be incorrectly considered normal on
the basis of standard structural and functional analysis.
When used in a research context, CMR can improve our
understanding of the inter-relationships between myocardial
tissue characteristics and cardiac function.See page 1112Fibrosis imaging has both the most thoroughly investi-
gated and the most widely used application of tissue char-
acterization by CMR, speciﬁcally using late gadolinium
enhancement (LGE) to identify areas of replacement ﬁbrosis
in the heart. From its origins in identifying areas of infarc-
tion in coronary disease and ischemic cardiomyopathy (4),
LGE has demonstrated the ability to identify regional scar
across a spectrum of cardiomyopathies (5) and to identify
patients at increased risk of adverse events (6).
Not all myocardial scar is evident as the discrete regions of
replacement ﬁbrosis visualized as LGE, however. Recent
investigation has increasingly focused on the use of contrast-
enhanced CMR techniques to detect diffuse interstitial
ﬁbrosis, which can often be present in the absence of overt
replacement scar. A variety of magnetic resonance imaging
pulse sequences and analysis methods have been described,
but, in general, all rely on the principle of quantifying
changes in the ratio of extracellular to intracellular volume in
the myocardium. Iles et al. (7) were the ﬁrst to conﬁrm that
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contents of this paper to disclose.degree of collagen deposition seen on endomyocardial biopsy
after cardiac transplantation. This correlation with ﬁbrosis at
biopsy has subsequently been conﬁrmed in a broader range
of cardiomyopathies (8). In both cases, the majority of pa-
tients studied had no evidence of scar by standard LGE
imaging.
At ﬁrst pass it may seem a straightforward assumption that
a change in collagen volume, as a marker of cardiac structural
change, would imply alterations in cardiac function, such as
an increase in passive stiffness. Although collagen quantity
contributes to these changes, qualitative aspects of collagen,
including the ultrastructural location of the ﬁbers and post-
translational modiﬁcations such as cross-linking, may be
stronger determinants of such functional changes (9).
The functional implications of collagen quantity changes,
measurable by CMR, versus those of collagen quality
changes, which are not, are not self-evident.
In this issue of the Journal, Ellims et al. (10) provide
important hemodynamic evidence to support the hypothesis
that diffuse ﬁbrosis measured by CMR T1 mapping can
predict such functional changes. In this study, 20 heart
transplant recipients referred for a clinically-indicated car-
diac catheterization underwent same-day CMR, echocar-
diography, right heart catheterization, and left ventricular
pressure-volume loop measurement. The key ﬁnding in
this report is a strong correlation between the passive
stiffness component of diastolic ﬁlling (b) and CMR mea-
surement of diffuse ﬁbrosis both by T1 time and calculated
extracellular volume fraction. The correlation between T1
time and b persisted after correction for other parameters on
multivariate analysis. Notably, no other clinical, hemody-
namic, or echocardiographic parameter was signiﬁcantly
correlated with pressure-volume loop–measured passive
stiffness, save for a borderline signiﬁcant association with
pulmonary capillary wedge pressure (r ¼ 0.47, p ¼ 0.06).
No correlation was reported between the CMR measure-
ments, or other parameters, and the time constant of iso-
volumic relaxation (s).
This carefully performed invasive hemodynamic study is
an important advance in understanding the role of diffuse
ﬁbrosis measurement as part of the evaluation of cardiac
disease in establishing a link between ﬁbrosis and passive
stiffness. There are, however, some important caveats with
regard to the participants studied when considering the
generalizability of these results to other populations. It is
possible that the qualitative aspects of collagen deposition
after transplantation play less of a role than in other disease
states. In addition to being limited to transplant recipients,
participants in this study were relatively young (mean age 49
years), primarily male (80%), and largely asymptomatic
(65%) at the time of study. As a group, these patients were
normotensive and had normal right and left heart ﬁlling
pressures. It is perhaps reassuring that values of b and
s measured in this study are comparable to those previously
reported in patients with symptomatic heart failure and
normal ejection fraction (11), indicating that the degree of
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1120diastolic abnormalities in the present study are within the
range of interest for evaluation of other patients. Whether
these ﬁndings will hold when applied to sicker, more
symptomatic populations requires additional study.
The potential implications of this work, and of diffuse
ﬁbrosis quantiﬁcation as a whole, are not limited to patients
with clinically evident cardiovascular diseases. Recent data
from a cohort of 1,231 patients enrolled in MESA (Multi-
Ethnic Study of Atherosclerosis) demonstrated that both
female sex and advancing age were associated with an
increased burden of ﬁbrosis using comparable CMR mea-
sures (12). These ﬁndings underscore the potential use of this
technique in understanding the epidemiology of cardiovas-
cular disease and point toward the promise of following their
evolution in longitudinal studies. Although serial invasive
hemodynamic studies in large populations are not possible,
large multicenter cohort studies using CMR are of proven
feasibility and value. Further well-conducted studies linking
physiology with imaging, such as the present work by Ellims
et al. (10), are needed to maximize this potential.
There is much to be gained by future work in exploring the
implications of diffuse ﬁbrosis in cardiac function. A well-
validated quantitative imaging measurement that strongly
correlates with invasively-measured hemodynamics would
be of tremendous future value to cardiovascular epidemi-
ology, the evaluation of patient response to therapy, and the
evaluation of new therapies for cardiovascular disease.
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